Skip to Main Content

Author Details

Christopher I Bayly
1986
55
26
PMIDPaper TitleJournal TitlePublished Year
37167319Development and Benchmarking of Open Force Field 2.0.0: The Sage Small Molecule Force Field.J Chem Theory Comput2023
36382113Best practices for constructing, preparing, and evaluating protein-ligand binding affinity benchmarks [Article v0.1].2022
34136662Non-bonded force field model with advanced restrained electrostatic potential charges (RESP2).Commun Chem2020
33604023Benchmark assessment of molecular geometries and energies from small molecule force fields.F1000Research2020
30834751Biomolecular Solvation Structure Revealed by Molecular Dynamics Simulations.Journal of the American Chemical Society2019
30512951Toward Learned Chemical Perception of Force Field Typing Rules.J Chem Theory Comput2019
30742770Assessing the Conformational Equilibrium of Carboxylic Acid via Quantum Mechanical and Molecular Dynamics Studies on Acetic Acid.Journal of Chemical Information and Modeling2019
30351006Escaping Atom Types in Force Fields Using Direct Chemical Perception.J Chem Theory Comput2018
26579779Correction to Small Molecule Hydration Free Energies in Explicit Solvent: An Extensive Test of Fixed-Charge Atomistic Simulations.Journal of Chemical Theory and Computation2015
26339862Toward Automated Benchmarking of Atomistic Force Fields: Neat Liquid Densities and Static Dielectric Constants from the ThermoML Data Archive.Journal of Physical Chemistry B2015
24633516Efficient calculation of SAMPL4 hydration free energies using OMEGA, SZYBKI, QUACPAC, and Zap TK.Journal of Computer-Aided Molecular Design2014
24412110Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.Bioorganic and Medicinal Chemistry Letters2014
24488306Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs.Journal of Computer-Aided Molecular Design2014
21821827Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.Journal of Biomolecular Screening2011
20206513Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.Bioorganic and Medicinal Chemistry Letters2010
19598266Using electronic polarization from the internal continuum (EPIC) for intermolecular interactions.Journal of Computational Chemistry2010
20728350Identification of a new biaryl scaffold generating potent renin inhibitors.Bioorganic and Medicinal Chemistry Letters2010
20150953Small molecule hydration free energies in explicit solvent: An extensive test of fixed-charge atomistic simulations.Journal of Chemical Theory and Computation2009
24826083Integrated Continuum Dielectric Approaches to treat Molecular Polarizability and the Condensed Phase: Refractive Index and Implicit Solvation.Journal of Chemical Theory and Computation2009
19665376Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.Bioorganic and Medicinal Chemistry Letters2009
19271713Predictions of hydration free energies from all-atom molecular dynamics simulations.Journal of Physical Chemistry B2009
18215013Predicting small-molecule solvation free energies: an informal blind test for computational chemistry.Journal of Medicinal Chemistry2008
23646034Accurate Molecular Polarizabilities Based on Continuum Electrostatics.Journal of Chemical Theory and Computation2008
18477508Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor.Bioorganic and Medicinal Chemistry Letters2008
18811135Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis.Journal of Medicinal Chemistry2008
17288412Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem.Journal of Chemical Information and Modeling2007
17591764Comparison of topological, shape, and docking methods in virtual screening.Journal of Chemical Information and Modeling2007
17408953Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.Bioorganic and Medicinal Chemistry Letters2007
17157022A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds.Bioorganic and Medicinal Chemistry Letters2007
17544269Primary amides as selective inhibitors of cathepsin K.Bioorganic and Medicinal Chemistry Letters2007
17238257Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space.Journal of Chemical Information and Modeling2007
16451072Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K.Journal of Medicinal Chemistry2006
16859286GLARE: a new approach for filtering large reagent lists in combinatorial library design using product properties.Journal of Chemical Information and Modeling2006
15686936Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.Bioorganic and Medicinal Chemistry Letters2005
16154747Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.Bioorganic and Medicinal Chemistry Letters2005
16023344Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.Bioorganic and Medicinal Chemistry Letters2005
14741294Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors.Bioorganic and Medicinal Chemistry Letters2004
15261289Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors.Bioorganic and Medicinal Chemistry Letters2004
15115390Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.Journal of Medicinal Chemistry2004
15013020Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors.Bioorganic and Medicinal Chemistry Letters2004
14980595Solid phase synthesis of selective caspase-3 peptide inhibitors.Bioorganic and Medicinal Chemistry2004
14516196The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.Biochemistry2003
12798321Nicotinyl aspartyl ketones as inhibitors of caspase-3.Bioorganic and Medicinal Chemistry Letters2003
12605861Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system.Analytical Biochemistry2003
12395429Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.Journal of Computational Chemistry2002
11352902The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase.Journal of Biological Chemistry2001
11457149An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis.J Am Chem Soc2001
11353841Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide.Proceedings of the National Academy of Sciences of the United States of America2001
10091674Structure-based design of COX-2 selectivity into flurbiprofen.Bioorganic and Medicinal Chemistry Letters1999
10091677Substituted furans as inhibitors of the PDE4 enzyme.Bioorganic and Medicinal Chemistry Letters1999
  • 1 - 50 of 55

Recommended Authors

Collaborators

University of California
Co-authored papers 4
Co-authored papers 3
Co-authored papers 2
University of California san francisco
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Co-authored papers 1
Co-authored papers 1
IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1